Table 4.
Infection-related | Noninfection-related | ||||||
---|---|---|---|---|---|---|---|
Characteristics | Follow-up time (32 361 person-years) | Deaths, n = 214 | asHR (95% CI) | P value | Deaths, n = 53 | asHR (95% CI) | P value |
Sex | |||||||
Male | 16 482 | 112 | – | 34 | 1.00 | ||
Female | 15 879 | 102 | – | 19 | 0.64 (0.36–1.13) | 0.125 | |
Current age (years)a | <0.001 | 0.049 0.050 | |||||
<1 | 173 | 24 | 7.46 (4.48–12.42) | <0.001 | 1 | 0.91 (0.12–6.88) | 0.925 |
1–4 | 3894 | 70 | 1.73 (1.21–2.47) | 0.003 | 12 | 1.56 (0.71–3.46) | 0.271 |
5–9 | 10 031 | 57 | 1.00 | 12 | 1.00 | ||
10–14 | 10 982 | 34 | 0.77 (0.50–1.18) | 0.234 | 9 | 0.80 (0.33–1.94) | 0.628 |
15–19 | 6201 | 24 | 1.36 (0.81–2.31) | 0.246 | 16 | 2.79 (1.26–6.22) | 0.012 |
20–24 | 1079 | 5 | 1.22 (0.45–3.36) | 0.695 | 3 | 2.51 (0.62–10.24) | 0.198 |
Current CD4+ cell count (cells/μl)a | <0.001 | 0.033 | |||||
<200 | 1629 | 124 | 1.00 | 15 | 1.00 | ||
200–349 | 1478 | 18 | 0.31 (0.18–0.53) | <0.001 | 6 | 0.84 (0.33–2.19) | 0.731 |
350–499 | 7223 | 28 | 0.18 (0.11–0.29) | <0.001 | 11 | 0.47 (0.20–1.14) | 0.095 |
≥500 | 17 628 | 11 | 0.05 (0.02–0.09) | <0.001 | 13 | 0.29 (0.13–0.67) | 0.004 |
Missing | 4403 | 33 | 8 | ||||
Current weight-for-age z-scorea | <0.001 | 0.020 | |||||
<−3 | 4327 | 146 | 1.00 | 22 | 1.00 | ||
≤−3 to <−2 | 6005 | 19 | 0.21 (0.13–0.34) | <0.001 | 9 | 0.56 (0.25–1.29) | 0.173 |
≥−2 | 17 636 | 26 | 0.15 (0.10–0.24) | <0.001 | 15 | 0.38 (0.19–0.75) | 0.005 |
Missing | 4392 | 23 | 7 | ||||
History of AIDS diagnosisa | |||||||
No | 14 796 | 17 | 1.00 | 7 | 1.00 | ||
Yes | 17 565 | 197 | 5.60 (3.30–9.30) | <0.001 | 46 | 4.13 (1.80–9.50) | <0.001 |
Currently on second-line cARTa | |||||||
No | 27 453 | 182 | 1.00 | 43 | 1.0 | ||
Yes | 4908 | 32 | 1.64 (1.08–2.50) | 0.020 | 10 | 1.21 (0.56–2.62) | 0.624 |
Facility setting | 0.212 | ||||||
Urban | 19 909 | 152 | 1.00 | 30 | – | ||
Mostly urban | 10 436 | 47 | 0.89 (0.64–1.23) | 0.476 | 17 | – | |
Mostly rural | 2016 | 15 | 0.61 (0.35–1.09) | 0.096 | 6 | – | |
Year of first cART | <0.001 | 0.100 | |||||
<2008 | 17 409 | 58 | 1.00 | 25 | 1.00 | ||
2008–1010 | 8898 | 109 | 1.51 (1.05–2.18) | 0.028 | 23 | 1.58 (0.82–3.06) | 0.171 |
2011–2013 | 4696 | 42 | 1.01 (0.66–1.55) | 0.978 | 4 | 0.52 (0.17–1.60) | 0.256 |
2014–2017 | 1358 | 5 | 0.27 (0.10–0.71) | 0.008 | 1 | 0.37 (0.05–2.84) | 0.280 |
Deaths due to noninfection underlying causes (n = 53) and those for which causes were unknown or not reviewed (n = 45) were competing events for deaths due to infection-related underlying causes (n = 214). Similarly, deaths due to infection-related underlying causes and those for which causes were unknown or not reviewed were competing events for deaths due to noninfection causes. 95% CI, 95% confidence interval; asHR, adjusted sub distribution hazard ratio; cART, combination antiretroviral therapy of three or more antiretrovirals.
Current age, CD4+ cell count, weight-for-age z-score, second-line, and AIDS were considered time-dependent variables.